ALLO 8-K 2026-09-02

Allogene Therapeutics, Inc. (ALLO) 8-K dated 2026-09-02 — accession 0001193125-26-379423. This URL is the filing, not the ALLO hub.

Allogene Therapeutics, Inc. (ALLO) is a biotechnology company listed on US.

Allogene Therapeutics, Inc. filed a 8-K on 2026-09-02. Accession 0001193125-26-379423.

Cached items: 5.02. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported ALLO revenue for 2026-06-30 was $4.6M. Net income was -$85.3M. ALLO currently screens at market cap $258.1M.

Not investment advice. The ALLO SEC hub lists recent forms. The stock page is the research view.